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Abstract 
     MitoNEET, a mitochondrial membrane protein with an unsymmetrical Fe-S cluster 
coordination, was compared to similar proteins within the Rieske and Ferredoxin families. Point 
mutations were introduced via site-directed mutagenesis to induce stability, greater retention of 
the cluster, and to uncover structural limitations of the protein. Mutations were made within the 
cluster coordination and within the hydrophobic core of the protein. Some of the cluster 
mutations displayed a natural affinity for nickel during immobilized metal-ion affinity 
chromatography. It is possible that these mutations aid in the formation of a chelate when 
exposed to nickel. Spectroscopic monitoring of changes in cluster stability under low pH 
conditions was used to compare cluster retention across mutations. Some of the cluster mutants 
displayed a significant increase in stability versus wild type and other mutated forms of the 
protein. The hydrophobic mutations were found to push structural limitations of the protein by 
disrupting the hydrophobic core, even in the presence of the stabilizing cluster mutations. These 
mutation results would benefit from further structural research.  
Introduction 
 
     Iron-sulfur clusters (Fe-S) are a common post-translational addition made to certain proteins, 
providing a structural element necessary to their function inside the cell. The mechanism of Fe-S 
formation is yet unknown, however proteins containing a Fe-S have been shown to play a part in 
intracellular signaling, redox potential, and electron transport.1,2 There are two common [2Fe-2S] 
clusters found within known proteins. First is the Rieske center, which contains a [2Fe-2S] 
cluster coordinated by two histidine and two cysteine residues. These are commonly expressed in 
proteins like cytochrome bc1 complex (Figure 1A).1 The second Fe-S is common to the 
ferredoxin group. Ferredoxin contains a four-cysteine residue coordination geometry around its 
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[2Fe-2S] cluster (Figure 1B). Apparent 
in Figure 1, both [2Fe-2S] cluster 
coordinations are symmetrical, and are 
evolutionarily conserved to stabilize and 
retain the cluster.   
     Within the last 10 years a new cluster 
coordination was revealed within 
mitoNEET, an outer mitochondrial 
membrane protein. This homodimeric 
protein contains the sequence asparagine-
glutamic acid-glutamic acid-threonine (N-
E-E-T), from which its name is derived.3 
MitoNEET displays a three cysteine and one histidine cluster coordination geometry, which 
contradicts symmetrical characteristic of both Reiske and ferredoxin [2Fe-2S] clusters (Figure 
2). MitoNEET’s cluster coordination was named the CCCH-type [2Fe-2S] binding motif. When 
reduced, the cluster contains an Fe2+ ([Ar]3d6), Fe3+ (Ar]3d5), and 2 S ([Ne] 3s23p4) molecules.1 
Whereas when oxidized, it contains 2 Fe3+ (Ar]3d5) and 2 S ([Ne] 3s23p4) molecules.1 Multiple 
proteins were found to contain this motif including: IscR, Miner1 and Grx3/4-Fra2, all of which 
deal with redox homeostasis of the cell.4 The redox potential of mitoNEET was found to be +35 
mV at pH 7.5, differing from the Reiske (+300 mV) and Ferredoxin (-300 mV) center.2 Different 
studies were done with these proteins by mutating their cluster coordination residues to mimic 
more stable coordinations under different conditions, such as pH, temperature, and 
Figure 1. A. Cytochrome bc1 complex (left), revealing the two 
histidine, two cysteine [2Fe-2S] Rieske cluster coordination. B. 
Ferredoxin (left), demonstrating the four cysteine [2Fe-2S] 
cluster coordination (right).1 
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concentration.5,6 These studies have lead to 
increased productivity and more efficient 
functionality within the cell.  
The structure of mitoNEET reveales a 
buried interface.7,7 A strand swap β-sheet 
hydrophobic core is at the center of each 
monomer which is flanked on either side by a 
loop cradle containing the [2Fe-2S] cluster. The 
residue of most importance in recent studies 
was the easily deprotonated H87 residue.8 The 
H87 residue was mutated to a cysteine at that 
position, creating a more distinguished Reiske 
center9. This mutation increased stability, 
especially when in the presence of Pioglitazone, 
a drug used in the treatment of type 2 diabetes.10,11 Previous stability research done on the H87C 
mutation made it a candidate for a source of double mutations.  Although we are aware of 
location and cluster stability habits of mitoNEET, its function and transfer behaviors are still 
unknown. Stability of ferredoxin and Rieske [2Fe-2S] give a good indication of how 
mitoNEET’s cluster would behave if substituted with a more stable cluster coordination.12 
Although it was suggested that this unique unstable cluster is intrinsic to the protein’s metabolic 
role. 
Figure 2. Wild type dimer mitoNEET demonstrating 
the unique CCCH-Type [2Fe-2S] binding motif. 
Each monomer is displayed (green/silver) and the 
[2Fe-2S] clusters (yellow/orange). The cluster 
coordination includes the following four residues at 
their designated positions: C72, C74, C83, H87.2 
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      The hydrophobic core is an important avenue of study for this protein. Disruption of the 
hydrophobic core can lead to an inability to retain the cluster. The hydrophobic core can also be 
utilized to obtain data on retention of the cluster and determine its structural limitations.  
     MitoNEET binds with pioglitazone.. Pioglitazone utilizes the protein’s 7 residue binding 
pocket to create a protein-drug complex, stabilizing mitoNEET’s [2Fe-2S] cluster.13,14 
MitoNEET was suggested to play a role in activation of glutamate dehydrogenase, an insulin 
regulator, by allowing a cysteine at the 74 position of mitoNEET to form a disulfide bond with a 
cysteine at the 319 position of the regulator.15,16 This research makes mitoNEET a topic for 
discussion due to the high number of people affected by type 2 diabetes.  
  
Experimental Details 
 
Site Directed Mutagenesis  
 
     WT MitoNEET sequence was analyzed utilizing Chromas (Technelysium, Australia). This 
sequence was used with Aligent’s primer design webtool to produce PCR primers for site 
directed mutagenesis (SDM). Primers were made to introduce point mutations in the Fe-S cluster 
cradle, in addition to residues that were thought to play a role in stabilizing the hydrophobic core. 
Residues altered by SDM are summarized in table 1. Since there is a significant amount of 
previous data on stability and effects of the H87C mutant, double mutants were made with H87C 
and various cluster cradle residues.17 (Table 1) Polymerase chain reaction (PCR) reactions were 
carried out with the following cycle condition: 30 seconds 95°, 14 cycles of 30 seconds at 95°, 
1 minute at 55 °, 4 minutes at 68°. The thermocycler was held at 4° until the the sample was 
ready to be removed. A QuickChange II XL Site-Directed Mutagenesis Kit (Aligent 
Technologies, Santa Clara, CA) was used. A pET3a expression vector with a T7-inducible 
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promoter, and ampicillin resistance gene was transformed into XL10-Gold ultracompetent cells, 
and the transformed cells were plated on LB/Ampicillin plates.18 
Table 1. This table displays mutated residues, position in the sequence, and location within mitoNEET. 
Also present is a overview of cluster coordination present following the mutation. 
Original Residue New Residue Position New Cluster 
Coordination 
Location of 
Mutation 
Name 
Histidine Cysteine 87 Ferredoxin Center  Cluster Cradle H87C 
Phenylalanine  Alanine 60 CCCH-Type Hydrophobic Core F60A  
Cysteine Histidine 83 Rieske Cluster Cradle C83H 
Cysteine  Histidine 74 Rieske Cluster Cradle C74H  
Cysteine  Histidine  72 Rieske Cluster Cradle C72H 
Histidine 
Cysteine 
Cysteine 
Histidine 
87 
83 
CCCH-Type  
(relocation of H) 
Cluster Cradle 
Cluster Cradle 
H87C 
C83H 
Histidine 
Cysteine 
Cysteine 
Histidine 
87 
74 
CCCH-Type  
(relocation of H) 
Cluster Cradle 
Cluster Cradle 
H87C 
C74H 
Histidine 
Cysteine 
Cysteine 
Histidine 
87 
72 
CCCH-Type  
(relocation of H) 
Cluster Cradle 
Cluster Cradle 
H87C 
C72H 
Histidine 
Glycine 
Cysteine 
Alanine 
87 
66 
Rieske Cluster Cradle 
Hydrophobic Core 
H87C 
G66A 
Histidine 
Tryptophan 
Cysteine 
Phenylalanine 
87 
75 
Rieske Cluster Cradle 
Hydrophobic Core 
H87C 
W75F 
 
Miniprep and Transformation 
 
    A Plasmid Miniprep II E.Z.N.A. kit was used to conduct the miniprep (Genex Technologies, 
OR). Plasmid vectors were transformed into ultracompetent XL10-Gold E. coli cells (Lucigen), 
where induced expression of mutation-containing vector produces high mitoNEET levels within 
the cells. 19 After plasmid miniprep, a bacterial transformation in C43 competent cells with 
expression media was done.20,21 An ampicillin resistance gene allows specific retention of cells 
that have incorporated the plasmid. By plating cells onto an ampicillin plate, all bacterial cells 
that do not have the ampicillin gene resistance will die, leaving cells viable for induced protein 
expression.  
 
Expression and Isolation of MitoNEET 
 
 7 
     2xYT media supplemented with ampicillin (100 /	
 was utilized to induce protein 
expression. A small 25 mL overnight culture was grown to stationary phase at 37° and 260 rpm 
using a 250 mL fernbach flask. This culture was used to inoculate a larger culture (500 mL) the 
following morning. Optical density (OD600) was taken every 20 minutes using a sample of 2xYT 
taken prior to inoculation as a negative control (Table 2).  
Table 2. Provides the actions taken at the corresponding optical density values. 
OD600 Action 
~0.200 Add 1 Iron (III) Chloride Solution 
~0.700 Drop temperature to 29° 
~0.800 Add 0.50 mM IPTG 
 
Large cultures were induced for 10 hours with 0.5 mM Isopropyl -D-1-thiogalactopyranoside 
(IPTG) after reducing the temperature to 18 °. Cells were pelleted by centrifugation at 14,000 
times gravity for 15 minutes. These pellets were stored at -20°.  
     Before lysis, pellets were allowed to thaw at room temperature for 30 min and resuspended in 
25 mL of wash buffer (50mM Tris-HCL pH 8.5, 200 mM NaCl, 20mM Imidazole). This was 
vortexed into solution to create a cell paste. At this point the protease inhibitors 
phenylmethanesulfonylfluoride (PMSF), leupeptin, and benzamidine were added. Cell paste was 
lysed using a French pressure cell. Three passes were utilized to ensure complete lysis. Crude 
lysate was centrifuged at 14000 times gravity for 12 minutes and supernatant was retained. The 
lysed supernatant was further purified utilizing a 0.22 μm syringe filter before injecting it into an 
ÄKTA fast protein liquid chromatography (FPLC) system for purification.  
     Immobilized metal ion affinity chromatography (IMAC) was used to isolate mitoNEET from 
unwanted lysate materials. The IMAC uses interactions between immobilized transition metals, 
in this case Ni 2+, and specific amino acid residues, such as histidine. Since the protein contains a 
6-Histidine tag, it coordinates Ni on the column resin and sticks to the His-Trap while everything 
 else is washed through the column into waste. 
gradient elution with buffer B (50mM Tris
Imidazole). Each of the fractions were assessed for protein content
curve was established to more accurately determine concentration
4). 22 
 
Table 3. (Left) Values utilized in producing the mitoNEET Bradford curv
Figure 3. (Right) The Bradford  curve produced by 
mitoNEET content in fractiosn lacking apparent color.
 
     Fractions determined to contain mitoNEET were 
(50 mM Tris-HCl pH 8.5, 300 mM NaCl) utilizing 10 kDa 
sample dialyzed for an hour prior to the addition of 
Dialysis was allowed to complete overnight (<18 hours). 
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0.100 mM 0.456 
0.200 mM 0.59 
0.260 mM 0.651 
0.300 mM 0.738 
0.400 mM 0.828 
0.519 mM  0.992 
Figure 4. The signature Bradford color differences in the presence of protein in a fraction. 
Concentration of mitoNEET from left to right: 0.40 mM, 0.30 mM, 0.20 mM, 0.10 mM, 0.075 mM, 
0.050 mM, 0.025 mM, 0.010 mM, 0.005 mM.
 MitoNEET was collected in fractions 
-HCL pH 8.5, 200 mM NaCl, 400mM/600mM
 via A280. A Bradford
 (Table 3, Figure 3 
e. 
Table 3. This Bradford curve was used
 
pooled and dialyzed in 1L of dialysis buffer 
SnakeSkin dialysis tubing. The 
thrombin to cleave the 6 histidine tag. 
A second FPLC was used to
y = 0.0961x - 0.1077
R² = 0.9959
0 2 4 6 8 10
[MitoNEET] (mM)
MitoNEET Bradford Standard Curve
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mitoNEET from the cleaved tag. Alternatively, size exclusion chromatography (SEC) was later 
used in lieu of a second HisTrap. The 6-His tag would be separated out in both procedures, 
making the second HisTrap useless. This sample was dialyzed to remove the imidazole.   
      Final step of purification was to use SEC as a polishing method, however a sample size of < 
2 mL was necessary. All mitoNEET samples were concentrated prior to being injected into the 
column. An Amicon stir cell with a 10 kDa filter was used to concentrate mitoNEET. 
Throughout isolation of mitoNEET, a 10 kDa filter was used because the cluster-containing 
dimer is approximately 22 kDa. It was optimal to filter for the dimer rather than the 11 kDa 
monomer. After concentration, it was injected into the size exclusion column and run through 
with SEC buffer (50 mM Tris pH 8.5, 150 NaCl). Size exclusion columns work by separating out 
different size compounds within a solution. Larger compounds flow over with little interaction 
with the resin and come through the column quickly. Monomer and dimer mitoNEET come off 
at specific volumes that correspond to their size. This way it is easy to select which form one 
would like to collect and concentrate. This column removes almost all imidazole present, which 
is helpful for nuclear magnetic resonance (NMR) experiments. Since this is a 100 mL column, it 
will severely dilute the sample. It is necessary to concentrate samples prior to using them in any 
type of assay or further experiment.  
 
pH-Dependent Cluster Stability   
 
     Three different citric acid buffers were made at a pH of 4, 5, and 6 at different concentrations. 
A concentration of 25  of mitoNEET was added to 50 mM, 75 mM, or 100 mM citric acid 
buffer in a final volume of 500 μL. Absorbance at 457 nm was collected in 10 minute intervals. 
At 457 nm is where the Fe-S cluster absorbs maximally, therefore monitoring cluster loss over 
time. Two mitoNEET samples were used, H87C G66A and wild type (WT). H87C G66A mutant 
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acted as a single mutant because the G66A mutation had no effect on the cluster or hydrophobic 
core. The goal of this experiment was to test pH stability of  WT and H87C mutant mitoNEET. If 
done correctly, the H87C mutant is significantly more stable than WT.  
 
H87C Mutant Natural Nickel Affinity 
 
      H87C mutants exhibited a natural nickel affinity therefore making the protein difficult to 
elute off the column and producing lower yields. Imidazole was used to release the 6-histidine 
tag from the column. If a higher imidazole concentration were employed in the elution buffer, it 
would override mitoNEET’s natural affinity for Ni. Before increasing imidazole concentration 
on an entire sample, one sample was split into two sections to support homogeneity within 
expression procedures leading up to the HisTrap. The first section was eluted using 400 mM 
imidazole buffer and the second using an increased 600 mM imidazole buffer. Absorbance at 
457 nm and 280 nm were both measured following fraction collection.   
 
MitoNEET X-Ray Crystallography 
 
  H87C, WT, and H87C C83H samples were concentrated between 12 mg/mL and 16 
mg/mL using a centrifuge10 kDa filter.23,24 Sitting drop method was used with the buffers found 
in Appendix B. They sat for 3-5 days and wells were checked for precipitation and crystals.  
 
Gel Electrophoresis 
 
 Sodium-dodecyl sulfate (SDS) was used in conjunction with a 15% polyacrylamide gel 
electrophoresis to determine purity of each protein sample. SDS is a detergent that denatures 
protein, allowing it to separate based on molecular weight. A sample was taken during each stage 
of synthesis and purification for each mutant. Samples were denatured and dyed with an equal 
volume of 2X SDS 10% 2-mercaptoethanol (BME) solution. This solution was added to the 
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density so it would remain in the well. They were heated to 95°, agitated and spun down. 1X 
TAE (tris base, acetic acid, and EDTA) buffer was added to the gel apparatus to keep the gel 
wet, aid in electrical current, and cooling to avoid melting. Samples and ladder were placed in 
the gel and run for 30 minutes at 200 mV. Coomaisse Brilliant Blue was used as the stain and 
water as destain to see protein bands on the gel.  
 
Results & Discussion 
 
Expression and Isolation of MitoNEET 
 
 Concentration of each protein was recorded along with amount and cluster presence via 
absorbance spectroscopy at 280 nm and 457 nm respectively (Table 4). Protein aggregated 
within the stir cell once it was at approximately 0.800 mM, therefore values were monitored and 
kept below this concentration. The only mutants that did not retain their cluster were W75F and 
C83H. W75F was a mutation found within the hydrophobic core, whereas the C83H was part of 
the cluster coordination. It is possible that the W75F mutation successfully disrupted the 
hydrophobic core, which may have altered the structure and released the cluster. All that can be 
drawn from the data thus far is that the H87C W75F mutant did not retain its cluster. W75F was 
explored further through size exclusion chromatography to determine its final configuration 
(Figure 5C). The C83H mutation relocates a histidine residue to the outermost portion of the 
cluster, leaving it to interact with the solvent. The histidine could have deprotonated and affected 
the stability of the cluster. The H87C and C83H double mutant is stable however the H87C could 
be over-compensating for the C83H. 
Table 4. Amount of each mutant successfully made and their [Fe-S] cluster presence via the 
457 nm absorbance reading. 
Mutation Concentration Amount (mL) Absorbance (457 nm) 
H87C 0.350 mM 1.5 mL 0.003 
 12
W75F 
H87C 
G66A 0.754 mM 1.8 mL 0.587 
F60A 0.554 mM 2.3 mL 0.511 
H87C 0.726 mM 3.8 mL 0.609 
C83H 0.334 mM 1.7 mL 0.009 
C74H 0.537 mM 1.2 mL 0.459 
C72H 0.621 mM 2.0 mL 0.501 
H87C 
C83H 0.634 mM 2. 4 mL 0.566 
H87C 
C74H 0.523 mM 1.5 mL 0.492 
H87C 
C72H 0.544 mM 1.6 mL 0.527 
WT 0.759 mM 4.2 mL 0.697 
 
 
     Size exclusion chromatography provided data on the molecular weight of each mitoNEET 
sample and its purity (Figure 5). This data was utilized to determine if mutants produced 
monomer or dimer configurations and the effect this had on the presence of the Fe-S cluster. 
Results for the majority of mutants were dimer and cluster-containing. The only difference was 
seen with the W75F mutant, which presented itself solely in the monomer configuration. WT and 
H87C mitoNEET are displayed for comparison of the cluster-containing dimer configuration 
elution at 115 mL (Figure 5B). One can see minor absorbance peaks early on in the 
chromatogram, but this is aggregated product coming off the column. The H87C W75F 
displayed none of the characteristic red color throughout purification, verifying the absence of 
the Fe-S cluster. This protein eluted from the column as a monomer, coming off around 155 mL 
(Figure 5C). The W75F mutation was created with the intention to affect the hydrophobic core. 
Mutating a hydrophilic tryptophan residue with a large hydrophobic phenylalanine seemed to 
perturbed the hydrophobic core, which explains the resulting apo-monomeric mitoNEET.2  
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A 
 
B 
 
C 
 
Figure 5. A. (Top) Cleaved WT mitoNEET coming off the size exclusion column as a dimer with some 
aggregated protein coming off at around 100 mL. B. (Middle) H87C mitoNEET coming off the size 
exclusion protein to display the consistency of the purification process. C. The bottom is the H87C W75F 
cleaved double mutant. This sample provided little dimer (small peak at 115 mL) and mostly all 
monomer (large peak at 150 mL). 
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        The chromatogram from the first IMAC run of the H87C mutant (not shown) displayed a 
step gradient elution. The mitoNEET protein has a 6-histidine tag on it, which coordinates with 
the Ni resin inside of the His-Trap column. The histidine tag will create a complex with the Ni 
until replaced by the imidazole, which essentially trades places with the tag. This gradient was 
intended to find the lowest concentration of imidazole to elute the protein without disturbing the 
Fe-S cluster, however it took up to 600 mM to successfully elute. This issue was not observed 
with any of the mutants made in the wild type background. The H87C mutants were presenting 
lower yields off of the Ni column in addition to the columns being stripped of their Ni. Ni and 
protein disappearing together in the presence of imidazole, suggested a chelate formation within 
the column. New preparations of the H87C G66A, H87C C83H, and H87C were split and 
exposed to two different imidazole buffer conditions. The H87C W75F mutant was exempt from 
this due to its apo-configuration. Product concentration was significantly greater when 600 mM 
elution buffer was utilized for all three mutants (Figure 6). The same products were tested for 
their cluster content with much less difference between groups. The difference in elution patterns 
between the H87C mutants and the WT, in addition to the differences in yield, suggests that there 
is a natural affinity for nickel in the H87C mutants. This implies the formation of a chelate 
complex forming within the HisTrap.   
 It was suggested that higher imidazole concentrations would affect the protein’s ability to 
retain its cluster. Imidazole, which is expected to be a poor ligand for the [Fe-S], at high 
concentrations may replace the H87 residue due to the structural similarities between the two 
compounds. This would ultimately displace the [Fe-S], making it hard for the protein to retain its 
cluster leading to overall loss of the cluster. The mechanism for how mitoNEET and imidazole 
interact is still unknown, however Figure 7 supports the hypothesis stated above. The results 
 were not drastic enough to stray away from the increased yields the 600 mM imidazole 
produced; therefore the imidazole remained elevated for H87C mutants.
Figure 6. Three mitoNEET mutants’ concentrations were tested after being exposed to two different 
elution buffers after IMAC, buffer 1 (50 mM Tris
(50 mM Tris- HCL, 300 mM NaCl, 600 mM imidizole).
 
Figure 7. Three mitoNEET mutants were tested for their cluster stability after being exposed to two 
different buffers, buffer 1 (50 mM Tris
Tris- HCL, 300 mM NaCl, 600 mM imidizole).
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       The gel electrophoresis (Figure 8
display that the procedures were working effectively 
protein in the final stages.  
 
Figure 8. Displays the purification process through samples at each point of the procedure. (1) IMAC 1 
flow through (2) IMAC 2 flow through (3) IMAC 1 product (4) IMAC 2 product (
product (7) Concentrated Product (8) SEC Product (9) Final concentrated product. 
     In order to test pH dependent cluster stability, a
absorbance value for both samples. Two mitoNEET
incubated in deionized water and absorbance at 457 nm was 
control was helpful to determine the 
displays that a minor initial loss of the cluster will 
removed from the shaded stock box. This could 
of the cluster under sub-optimal buffer conditions
almost-identical behavior and composition to the H87C single mutant. The single mutant H87C 
) accurately displayed the purification process. The bands 
to select for the dimer mitoNEET
5) Ladder (6) Dialized 
 
 control was conducted to establish 
 samples, WT and H87C G66A, were 
monitored over time (Figure 
amount of protein necessary to obtain results. Figure 
occur in both WT and H87C G66A 
have been exposure to light and/or a natural loss 
25
. The H87C G66A was chosen because of its 
16
 (22 kDa) 
 
a starting 
9). A 
9 
once 
 mitoNEET was unavailable, therefore the H87C G66A was the best option to observe the 
variability in cluster stability between WT and H87C Rieske 
Figure 9. The control to see at which concentration, 25 uM or 50 uM, an accurate 457 nm absorbance 
rating. 
     Wild type, after being treated with 100 mM citric acid buffers at pH values of 4, 5, and 6
displayed a continual loss of Fe-S cluster over time at all pH
in pH 6 compared to pH 4 and 5 (Figure 
a pH of about 8-8.5. Anywhere outside of the pH range 7.5
mitoNEET to retain its Fe-S cluster. Th
followed by the sample at pH 5. This rate 
trend line ( R2 = 0.94469). The direct 
more extreme the pH change, the faster the rate of loss. 
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, 
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 Figure 10. Wild type mitoNEET treated with 100 mM
over time to determine the rate of [Fe-
at pH 4, pH 5, and pH 6. 
     Wild type mitoNEET was monitored again at pH 5
and protein were varied in this experiment. There was little difference 
between mitoNEET concentrations. Citric acid buffers at 
stability, which is apparent in the 25 
interactions because of the lower concentration. 
worked similarly to remove the cluster. 
end This could be due to a dirty cuvette, unreliable blan
blank.  
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 citric acid 
-acid 
 Figure 11. Two concentrations of wild typoe mitoNEET were employed, 25 uM and 50 uM. The pH was 
kept constant, with the concentration of citric acid ranging from 50 mM to 100 mM.
457nm absorbance was monitored over time.
 
      H87C G66A mitoNEET mutant was exposed to the same conditions. There was a significant 
difference in rate of cluster loss between the 50 
concentration of 50  mitoNEET displayed a high rate of loss, however this could be 
this sample had more to lose. There was no significant difference between the varying 
concentrations of citric acid. As one would suspect, the higher the c
cluster loss, but the rate is not significantly different.
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At a 
because 
 Figure 12. The mitoNEET double mutant H87C G66A was treated with a citric acid buffer at 50 mM, 75 
mM, and 100 mM. All of the buffers remained constant at a pH of 5
two concentrations of mitoNEET, 25 uM and 50 uM.
      H87C G66A mutant was monitored visually as it was treated with each pH buffer. This 
experiment corresponds to Figure 13
resulted. This data visually re-affirms 
higher the rate of loss. One can see color is gone in < 60 minutes at pH 4, >120 minutes at pH 5, 
and stays >180 minutes at pH 6.  
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. There was a steady decrease in color until a clear solution 
the conclusion that the farther away from optimal pH, the 
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 Figure 13. MitoNEET H87C G66A was treated with 100 mM citric acid buffer at three different pHs, 4, 
5, and 6. The color of the cluster was monitored visually every 30 minutes
 
     The crystallography trails were inconclusive 
solution prior to running crystal trials. 
 
Conclusion 
      Based on the experiments used to determine the effects of pH
H87C mutation significantly increases the stability of the [2Fe
double mutation, H87C C83H, increases [2Fe
This relocation exposes the residue to the outermost portion of the cradle where it can interact 
with the solvent. However the single C83H mut
comparison between all of the mutations and H87C W75F suggests that this mutation perturbs 
the hydrophobic core and facilitates [2Fe
mutation. It was also concluded that the H87C mutants have a natural nickel affinity, possibly 
forming a chelate.  
. 
because the protein denatured and ca
 
, it was confirmed that the 
-2S] cluster. In addition, the 
-2S] retention due to the relocation of the histidine. 
ation somehow decreases cluster retention. 
-2S] loss even in the presence of the stabilizing H87C 
21
 
me out of 
The 
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     Obtaining the crystal structure of each mutation would be helpful in observing their structural 
effects. Further crystallization trials will be conducted to determine the stability mechanisms of 
the H87C C83H and disruption of the hydrophobic core in the H87C W75F mutation.   
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Appendix 1 – Safety Procedures 
 
General Safety Protocols 
• Appropriate personal protective equipment (PPE) was worn at all times while working in the 
lab to avoid contamination and skin exposure to chemicals.  
 
Biohazard Material  
• When handling bacteria and cells, all equipment was disposed of in biohazard waste 
containers or cleaned with bleach directly after use. 
 
Chemicals 
• All material and safety data sheets (MSDS) were consulted prior to handling any reagents 
within the lab. When handling chemicals, gloves were worn at all times to avoid any contact.  
• Chemicals deemed dangerous such as unpolymerized acrylamide were handled with care 
under direct supervision. 
 
Instruments 
• All instruments were operated after adequate training on each machine. All instrumentation 
was used under supervision.  
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Appendix 2 – Crystallographic Conditions 
 
Plate # Conditions 
1 100mM Tris pH 8.0, 30% PEG 4000, 50 mM Sodium Chloride 
2 100mM Tris pH 8.0, 30% PEG 4000, 50mM Sodium Chloride 
3 100mM Tris pH 8.0, 30% PEG 4000, 100 mM Sodium Chloride 
4 100mM Tris pH 8.0, 30% PEG 4000, 100 mM Sodium Chloride 
5 100mM Tris pH 8.0, 30% PEG 4000, 200 mM Sodium Chloride 
6 100mM Tris pH 8.0, 30% PEG 4000, 200 mM Sodium Chloride 
7 100mM Tris pH 8.0, 30% PEG 4000, 300 mM Sodium Chloride 
8 100mM Tris pH 8.0, 30% PEG 4000, 300 mM Sodium Chloride 
9 100mM Tris pH 8.0, 30% PEG 4000, 50 mM Lithium Chloride 
10 100mM Tris pH 8.0, 30% PEG 4000, 50 mM Lithium Chloride 
11 100mM Tris pH 8.0, 30% PEG 4000, 100 mM Lithium Chloride 
12 100mM Tris pH 8.0, 30% PEG 4000, 100 mM Lithium Chloride 
13 100mM Tris pH 8.0, 30% PEG 4000, 200 mM Lithium Chloride 
14 100mM Tris pH 8.0, 30% PEG 4000, 200 mM Lithium Chloride 
15 100mM Tris pH 8.0, 30% PEG 4000, 300 mM Lithium Chloride 
16 100mM Tris pH 8.0, 30% PEG 4000, 300mM Lithium Chloride 
17 100mM Tris pH 8.0, 30% PEG 4000, 50mM Lithium Sulfate 
18 100mM Tris pH 8.0, 30% PEG 4000, 50mM Lithium Sulfate 
19 100mM Tris pH 8.0, 30% PEG 4000, 100mM Lithium Sulfate 
20 100mM Tris pH 8.0, 30% PEG 4000, 100mM Lithium Sulfate 
21 100mM Tris pH 8.0, 30% PEG 4000, 200mM Lithium Sulfate 
22 100mM Tris pH 8.0, 30% PEG 4000, 200mM Lithium Sulfate 
23 100mM Tris pH 8.0, 30% PEG 4000, 300mM Lithium Sulfate 
24 100mM Tris pH 8.0, 30% PEG 4000, 300mM Lithium Sulfate 
25 100mM Tris pH 8.0, 30% PEG 4000, 50mM SodiumAcetate 
26 100mM Tris pH 8.0, 30% PEG 4000, 50mM Sodium Acetate 
27 100mM Tris pH 8.0, 30% PEG 4000, 100mM Sodium Acetate 
28 100mM Tris pH 8.0, 30% PEG 4000, 100mM Sodium Acetate 
29 100mM Tris pH 8.0, 30% PEG 4000, 200mM Sodium Acetate 
30 100mM Tris pH 8.0, 30% PEG 4000, 200mM Sodium Acetate 
31 100mM Tris pH 8.0, 30% PEG 4000, 300mM Sodium Acetate 
32 100mM Tris pH 8.0, 30% PEG 4000, 300mM Sodium Acetate 
33 100mM Tris pH 8.0, 30% PEG 4000, 50mM Magnesium Chloride 
34 100mM Tris pH 8.0, 30% PEG 4000, 50mM Magnesium Chloride 
35 100mM Tris pH 8.0, 30% PEG 4000, 100mM Magnesium Chloride 
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36 100mM Tris pH 8.0, 30% PEG 4000, 100mM Magnesium Chloride 
37 100mM Tris pH 8.0, 30% PEG 4000, 200mM Magnesium Chloride 
38 100mM Tris pH 8.0, 30% PEG 4000, 200mM Magnesium Chloride 
39 100mM Tris pH 8.0, 30% PEG 4000, 300mM Magnesium Chloride 
40 100mM Tris pH 8.0, 30% PEG 4000, 300mM Magnesium Chloride 
41 100mM Tris pH 8.0, 30% PEG 4000, 50 mM Ammonium Sulfate 
42 100mM Tris pH 8.0, 30% PEG 4000, 50 mM Ammonium Sulfate 
43 100mM Tris pH 8.0, 30% PEG 4000, 100 mM Ammonium Sulfate 
44 100mM Tris pH 8.0, 30% PEG 4000, 100 mM Ammonium Sulfate 
45 100mM Tris pH 8.0, 30% PEG 4000, 200 mM Ammonium Sulfate 
46 100mM Tris pH 8.0, 30% PEG 4000, 200 mM Ammonium Sulfate 
47 100mM Tris pH 8.0, 30% PEG 4000, 300 mM Ammonium Sulfate 
48 100mM Tris pH 8.0, 30% PEG 4000, 300 mM Ammonium Sulfate 
 
 
 
 
